Application 021762
- Type
- NDA
- Sponsor
- MERCK
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | FOSAMAX PLUS D | ALENDRONATE SODIUM; CHOLECALCIFEROL | TABLET;ORAL | EQ 70MG BASE;2,800 IU | Yes | No |
| 002 | FOSAMAX PLUS D | ALENDRONATE SODIUM; CHOLECALCIFEROL | TABLET;ORAL | EQ 70MG BASE;5,600 IU | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021762-001 | FOSAMAX PLUS D | ALENDRONATE SODIUM; CHOLECALCIFEROL | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | |
| N021762-002 | FOSAMAX PLUS D | ALENDRONATE SODIUM; CHOLECALCIFEROL | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | 87673890dc5c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | 5aa47cf7b7d7… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | 8869cabd3fbd… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | c0c555d07b60… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | 9b2671bbb829… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | 3f0d92c62455… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | 053a50430f4f… | |
| 2023-05-13 08:27 UTC | 2023-05 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | 3bdfa0b2c4d7… | |
| 2023-01-26 05:58 UTC | 2023-01 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021762-001 | FOSAMAX PLUS D | EQ 70MG BASE;2,800 IU | TABLET / ORAL | RLD | 2005-04-07 | 3a93d1ddd44b… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021762-002 | FOSAMAX PLUS D | EQ 70MG BASE;5,600 IU | TABLET / ORAL | RLD, RS | 2007-04-26 | 3a93d1ddd44b… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021762-001 | 5994329*PED | 2019-01-17 | Pediatric extension | 74a2ff9319b5… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N021762-001 | 5994329*PED | 2019-01-17 | Pediatric extension | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N021762-001 | 5994329*PED | 2019-01-17 | Pediatric extension | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N021762-001 | 5994329*PED | 2019-01-17 | Pediatric extension | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FOSAMAX PLUS D | ALENDRONATE SODIUM AND CHOLECALCIFEROL | Organon LLC | 10307e7e-9a84-4aa1-8c5c-4b209cffe4d1 | 2026-02-03 | Warnings, Adverse reactions | 021762 NDA021762 78206-137 78206-136 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0006-0270 | FOSAMAX PLUS D | ALENDRONATE SODIUM and CHOLECALCIFEROL | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-0270 | FOSAMAX PLUS D | ALENDRONATE SODIUM and CHOLECALCIFEROL | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-0270 | FOSAMAX PLUS D | ALENDRONATE SODIUM and CHOLECALCIFEROL | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-0270 | FOSAMAX PLUS D | ALENDRONATE SODIUM and CHOLECALCIFEROL | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-0710 | FOSAMAX PLUS D | ALENDRONATE SODIUM and CHOLECALCIFEROL | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-0710 | FOSAMAX PLUS D | ALENDRONATE SODIUM and CHOLECALCIFEROL | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-0710 | FOSAMAX PLUS D | ALENDRONATE SODIUM and CHOLECALCIFEROL | Merck Sharp & Dohme Corp. | NDA | Current |
| 0006-0710 | FOSAMAX PLUS D | ALENDRONATE SODIUM and CHOLECALCIFEROL | Merck Sharp & Dohme Corp. | NDA | Current |
| 78206-136 | FOSAMAX PLUS D | ALENDRONATE SODIUM and CHOLECALCIFEROL | Organon LLC | NDA | Current |
| 78206-136 | FOSAMAX PLUS D | ALENDRONATE SODIUM and CHOLECALCIFEROL | Organon LLC | NDA | Current |
| 78206-136 | FOSAMAX PLUS D | ALENDRONATE SODIUM and CHOLECALCIFEROL | Organon LLC | NDA | Current |
| 78206-137 | FOSAMAX PLUS D | ALENDRONATE SODIUM and CHOLECALCIFEROL | Organon LLC | NDA | Current |
| 78206-137 | FOSAMAX PLUS D | ALENDRONATE SODIUM and CHOLECALCIFEROL | Organon LLC | NDA | Current |
| 78206-137 | FOSAMAX PLUS D | ALENDRONATE SODIUM and CHOLECALCIFEROL | Organon LLC | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 84931 | SUPPL | 2026-02-05 |
| 84930 | SUPPL | 2026-02-05 |
| 84914 | SUPPL | 2026-02-05 |
| 59790 | SUPPL | 2019-08-21 |
| 59789 | SUPPL | 2019-08-21 |
| 59752 | SUPPL | 2019-08-20 |
| 37604 | SUPPL | 2015-12-02 |
| 6141 | SUPPL | 2015-12-01 |
| 6140 | SUPPL | 2015-04-13 |
| 16330 | SUPPL | 2015-04-10 |
| 37603 | SUPPL | 2013-11-08 |
| 28548 | SUPPL | 2013-11-08 |
| 23296 | ORIG | 2013-05-09 |
| 37602 | SUPPL | 2013-04-23 |
| 28547 | SUPPL | 2013-04-23 |
| 28546 | SUPPL | 2011-07-06 |
| 6139 | SUPPL | 2011-01-27 |
| 37601 | SUPPL | 2011-01-26 |
| 28545 | SUPPL | 2010-03-03 |
| 28544 | SUPPL | 2010-03-03 |
| 6138 | SUPPL | 2010-03-03 |
| 37600 | SUPPL | 2010-03-02 |
| 16329 | SUPPL | 2010-03-02 |
| 16327 | SUPPL | 2010-03-02 |
| 16328 | SUPPL | 2008-11-07 |
| 6137 | SUPPL | 2008-10-09 |
| 44150 | ORIG | 2008-01-07 |
| 28543 | SUPPL | 2007-05-01 |
| 16326 | SUPPL | 2007-05-01 |
| 37599 | SUPPL | 2007-01-08 |
| 37598 | SUPPL | 2007-01-08 |
| 6136 | SUPPL | 2007-01-08 |
| 6135 | SUPPL | 2007-01-08 |
| 21807 | ORIG | 2006-06-08 |
| 37597 | SUPPL | 2005-11-08 |
| 28542 | SUPPL | 2005-11-08 |
| 37596 | ORIG | 2005-04-12 |
| 28541 | ORIG | 2005-04-12 |